Chief Executive Officer - Recensione dipendente - Chief Executive Officer presso MaaT Pharma

5,0
6 feb 2022
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Patient focus company Team spirit Breakthrough Late stage

Svantaggi

New field coming with challenges

Esplora altre recensioni su MaaT Pharma

5,0
2 feb 2024
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Patient focus Late stage & well financed

Svantaggi

Hard workers Level of excellence is high

4,0
27 nov 2025
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Bonne organisation , projects interessants et promotteurs

Svantaggi

Une biotech donc fragilité financière

Vedi recensioni per: Utile|Valutazione|Data|Tutto